![Mark Evans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Evans
Président chez Obotritia Capital KGaA
Profil
Mark Evans is currently the Chairman-Supervisory Board at Obotritia Capital KGaA and a Partner at Albemarle Life Sciences LLP.
Previously, he served as a Non-Independent Non-Executive Director at ReNeuron Group Plc from 2020 to 2022 and as a Partner at Taube Hodson Stonex Partners LLP from 1998 to 2016.
He obtained his undergraduate degree from the University of Bristol.
Postes actifs de Mark Evans
Sociétés | Poste | Début |
---|---|---|
Obotritia Capital KGaA
![]() Obotritia Capital KGaA Real Estate DevelopmentFinance Obotritia Capital KGaA is a private investment firm that focuses on listed and unlisted markets. Its portfolio includes real estate, venture capital, and financial services. The company was founded by Rolf Elgeti on February 3, 2015 and is headquartered in Potsdam, Germany. | Président | - |
Albemarle Life Sciences LLP | Corporate Officer/Principal | - |
Anciens postes connus de Mark Evans
Sociétés | Poste | Fin |
---|---|---|
RENEURON GROUP PLC | Directeur/Membre du Conseil | 22/03/2022 |
Taube Hodson Stonex Partners LLP
![]() Taube Hodson Stonex Partners LLP Investment ManagersFinance Taube Hodson Stonex Partners LLP (THS) is the equity asset management subsidiary of GAM International Management Ltd., ultimately held by GAM Holding AG (SW: GAM, ADR: GMHLY) in Switzerland. Founded by Nils Taube, John Hodson and Cato Stonex in 1997, the firm is based in London and is a socially responsible investor which manages in-house funds that are open to investment by private, intermediaries and institutional investors. Their flagship is the International Growth and Value Fund. | Corporate Officer/Principal | 01/01/2016 |
Formation de Mark Evans
University of Bristol | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
RENEURON GROUP PLC | Health Technology |
Entreprise privées | 3 |
---|---|
Taube Hodson Stonex Partners LLP
![]() Taube Hodson Stonex Partners LLP Investment ManagersFinance Taube Hodson Stonex Partners LLP (THS) is the equity asset management subsidiary of GAM International Management Ltd., ultimately held by GAM Holding AG (SW: GAM, ADR: GMHLY) in Switzerland. Founded by Nils Taube, John Hodson and Cato Stonex in 1997, the firm is based in London and is a socially responsible investor which manages in-house funds that are open to investment by private, intermediaries and institutional investors. Their flagship is the International Growth and Value Fund. | Finance |
Obotritia Capital KGaA
![]() Obotritia Capital KGaA Real Estate DevelopmentFinance Obotritia Capital KGaA is a private investment firm that focuses on listed and unlisted markets. Its portfolio includes real estate, venture capital, and financial services. The company was founded by Rolf Elgeti on February 3, 2015 and is headquartered in Potsdam, Germany. | Finance |
Albemarle Life Sciences LLP |